Show simple item record

dc.contributor.authorHealth Research Consent Declaration Committee (HRCDC)
dc.descriptionAfter two years when our work reflected the impact of the COVID-19 pandemic, 2022 was a year when the work of the HRCDC and Secretariat began to return to a more normal footing. It was also the first full year of operation following the introduction of substantial amendments to the Health Research Regulations, which enable researchers to process personal health data in specific circumstances without the requirement for explicit consent, subject to meeting other data protection safeguards. The Committee met ten times during 2022 and considered applications for new research studies across a variety of different health research areas, although there were fewer applications relating to COVID-19-focused research than in the previous two years. There was an increase in the number of applications for amendments to existing declarations. With more HRCDC consent declarations in place, 2022 also saw a continuing increase in the volume of annual reviews submitted by applicants, which are a core component in monitoring the operation and implementation of consent declarations. The HRCDC reviewed and updated a number of its core operating procedures over the course of 2022, including those for consent declaration amendment requests and applications considered by written procedure. For the first time since March 2020, the Committee was able to hold two meetings in person in 2022 and looks forward to convening in the future via a hybrid model of remote and in-person meetings.en_US
dc.publisherHealth Research Consent Declaration Committee (HRCDC)en_US
dc.rightsAttribution 4.0 International*
dc.titleHealth Research Consent Declaration Committee (HRCDC) annual activities report 2022en_US

Files in this item

HRCDC-Annual-Activities-Report ...

This item appears in the following Collection(s)

Show simple item record

Attribution 4.0 International
Except where otherwise noted, this item's license is described as Attribution 4.0 International